中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2024, Vol. 23 ›› Issue (03): 197-199,218.doi: 10.3969/j.issn.1671-4091.2024.03.009
Previous Articles Next Articles
LOU Fang-fang, LIU Xiao-yi, XIE Chao, KONG Yao-zhong
Received:
Revised:
Online:
Published:
Contact:
Abstract: Peritoneal dialysis (PD) is now widely used in the long-term treatment of patients with end stage renal disease (ESRD). Encapsulating peritoneal sclerosis (EPS) is a rare and serious complication of long-term PD patients with a high morbidity and mortality rate. The clinical symptoms of EPS mainly include irregular, persistent or frequent gastrointestinal obstruction symptoms often accompanied by severe abdominal pain, nausea, and vomiting. Imaging mostly shows progressive fibrotic thickening and sclerosis of the peritoneum, leading to intestinal encapsulation and followed by partial or complete intestinal obstruction. The purpose of this review is to introduce the pathogenesis of EPS and the progress of its diagnosis and treatment.
Key words: Peritoneal dialysis, Encapsulating peritoneal sclerosis, Pathogenesis, Diagnosis, Treatment
CLC Number:
R459.5
LOU Fang-fang, LIU Xiao-yi, XIE Chao, KONG Yao-zhong. Advances in the diagnosis and treatment of encapsulated peritoneal sclerosis in peritoneal dialysis patients[J]. Chinese Journal of Blood Purification, 2024, 23(03): 197-199,218.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2024.03.009
https://www.cjbp.org.cn/EN/Y2024/V23/I03/197